Shjnj Pharmaceutical Technologies Inc.

Bicalutamide

• Category :

  Intermediates/Pharmaceutical intermediates

• Synonyms :

  Bicalutamide (Subject to patent free);4-cyano-3-trifluoromethyl-N-(3-p-fluorophenylsulfonyl-2-hydroxy-2-methylpropionyl)aniline;N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenyl)sulfonyl-2-hydroxy-2-methyl-propanamid;[(4- fluorophenyl) sulfonyl]-2-hydroxy- 2-methyl propanamide ;N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanamide;(2S)-N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanamide;

• CAS NO :

  90357-06-5

• EC NO :

• Molecular Formula :

  C₁₈H₁₄F₄N₂O₄S

• Molecular Weight :

  430.3734

• Main Specifications :

• InChI :

  InChI=1/C18H14F4N2O4S/c1-17(26,10-29(27,28)14-6-3-12(19)4-7-14)16(25)24-13-5-2-11(9-23)15(8-13)18(20,21)22/h2-8,26H,10H2,1H3,(H,24,25)/t17-/m1/s1

• Packing :

  200mg

• Uses :

  It inhibits tumor cell growth and can be used as a first-line palliative treatment for advanced prostate cancer.

• Molecular Structure :